Although pituitary disorders are somewhat common, transitioning care from the pediatric endocrinologist to adult care can be challenging.
An in-depth symposia “Pituitary Disorders through the Life Cycle” on Friday will help sort out some of these challenges.
“We hope attendees will take away new clinical approaches to optimizing the health of patients with pituitary disorders, both in terms of how we treat adults who have had hypopituitarism since childhood and how we help patients achieve their dream of fertility and optimize their lifestyle and their quality of life with growth hormone,” said session Chair Susan Samson, MD, PhD, FRCPC, FACE, who is Medical Director of the Pituitary Center and Associate Professor of Medicine at Baylor College of Medicine.
Three speakers will address the transition of care and issues that may begin in childhood but affect a patient into adulthood.
“All three of these speakers have amazing clinical expertise in the pituitary world, and I’m really looking forward to them providing us with essential clinical guidance in how we should be monitoring and treating our patients with these disorders,” she said.
Laurence Katznelson, MD, Professor of Neurosurgery and Medicine and Medical Director of the Pituitary Center at Stanford University School of Medicine, will address the management of pituitary disorders in pregnancy and how to optimize a female patient’s care prior to desiring pregnancy and prior to conception. “How do we optimize hormonal replacement for the pituitary? If a patient is hypopituitary but still desires pregnancy, how can we improve the possibility that they can get pregnant? What kind of multidisciplinary team and approaches are required for success for that patient?” said Dr. Samson.
Dr. Katznelson’s talk will be followed by a presentation on transitioning care from childhood to adolescence to the adult clinic by Laurie Cohen, MD, Clinical Chief, Division of Endocrinology and Associate Professor of Pediatrics at Harvard Medical School.
“Dr. Cohen will talk about long-term cancer survivors, children who have been through treatments for brain tumors and craniopharyngiomas and other conditions requiring exposure to radiation and surgery and with the potential to become hypopituitary if they aren’t already, and how to transition those patients smoothly from a pediatric environment through to the adult environment,” said Dr. Samson.
Kevin Yuen, MD, FACE, medical director of the Barrow Pituitary Center and the Barrow Neuroendocrinology Clinic, will wrap up the symposium with an update on growth hormone testing and replacement. Dr. Yuen, who is leading the current drafted update on the AACE guidelines for growth hormone deficiency and treatment, will be discussing the ways to transition adolescents who had growth hormone deficiency and whether it is really necessary to treat them as an adult.
“Testing for growth hormone deficiency in the adult has become more challenging with the loss of the insulin tolerance test and the growth hormone releasing hormone arginine test,” said Dr. Samson. “Dr. Yuen has been one of the leaders in the field to look at the validation of additional stimulation tests as well as when should we actually be using this in these patients.”
Session Notes: F31: Pituitary Disorders through the Life Cycle 9:15 am on Friday in Room 208 Susan Samson, MD, PhD, FRCPC, FACE, will serve as moderator.